Hims Weight Loss
Fastest access, no labs
Lowest-friction start. Good for self-directed patients.
Quick take
- Hims is the fastest-onboarding GLP-1 program in the category — 2–3 days from signup to shipped medication is typical.
- Flat $199/month includes compounded GLP-1 medication plus provider access. Simplicity is the product.
- No labs required in most states at initial prescription. Minimal clinical depth — this is not a boutique program.
- No insurance acceptance. Intended for self-directed, cash-pay patients who don't want friction.
- Clinical rigor is the weakest of any major program reviewed; patients with comorbidities should go elsewhere.
Pros and cons
- Fastest signup-to-shipment in the category. Medication often arrives within 72 hours.
- Flat $199/month includes compounded medication — no surprise drug costs on top.
- Simple, well-designed app; dose tracking and side effect logging are clean.
- Brand recognition and operational maturity — Hims has been running telehealth for years and the logistics show.
- Good for self-directed patients who've already done their own research and just want access.
- Transparent pricing, no hidden fees, cancel anytime.
- Clinical depth is the thinnest of the major programs — short intake, minimal follow-up, no behavioral support.
- No labs required in most states is a feature for convenience but a bug for quality; some comorbidities will go undetected.
- No insurance acceptance; patients with commercial coverage are dramatically overpaying.
- Compounded-only for GLP-1s in most states; no brand-name Zepbound or Wegovy option.
- Provider continuity is weak — expect a different provider each visit.
- No dietitian component. No behavioral coaching. No plateau protocol.
What Hims actually is
Hims (and sister brand Hers) is a major generalist telehealth company that added weight-management/GLP-1 services in 2023–2024. The company's core advantage is distribution and brand — Hims is one of the most recognized names in consumer telehealth.
The GLP-1 product: $199/month flat fee that bundles compounded GLP-1 medication (semaglutide or tirzepatide depending on availability) with prescriber access. Unlike Ro or Mochi, the membership and medication aren't separated.
The positioning is clear: fastest path to a GLP-1, minimal friction, no insurance work. It's the right product for a specific customer — the self-directed adult who's researched GLP-1s, decided to try one, and wants to start quickly without a multi-week clinical process.
The sign-up experience
Hims has optimized intake for speed, not thoroughness. Expect 8–10 minutes. Questions cover BMI, basic medical history, prior weight-loss attempts, and contraindications (thyroid cancer history, pregnancy status, pancreatitis). A licensed prescriber reviews within hours — often the same day.
No labs are required in most states at first prescription. Medication ships within 48–72 hours. This is genuinely fastest in the category.
The flip side: the intake is short because the clinical process is thin. A thorough obesity medicine intake catches undiagnosed conditions (subclinical hypothyroidism, prediabetes, liver disease) that affect treatment. Hims explicitly leaves that to your PCP.
Clinical depth: intentionally thin
Hims is not a clinical program. It's a prescription fulfillment service with a licensed prescriber in the loop. The prescriber reviews your intake, prescribes if appropriate, and signs off on refills.
There's no scheduled follow-up cadence, no dietitian, no behavioral coaching, no structured protocol. If you have a question, you message and a provider — usually not the one who prescribed — responds within 24–48 hours.
For a patient who already has a good PCP, who knows their baseline labs are clean, and who wants a GLP-1 without the 2–3 weeks of clinical onboarding elsewhere, Hims is appropriate. For anyone with complex history, untreated comorbidities, or need for ongoing clinical judgment, Hims is explicitly not the right program.
Pricing: what you actually pay
Flat $199/month — includes compounded semaglutide or tirzepatide (whichever Hims' pharmacy network has available) and all prescriber access.
That's the whole price. No separate medication cost, no platform fee on top. The simplicity is real.
Brand-name option: Hims added a brand-name Wegovy Pill option in early 2026 at $149–$299/month (promotional pricing that typically increases at month 4). As of April 2026, Hims does not offer brand-name Zepbound or Wegovy injectable at scale in most markets.
No insurance acceptance. If you have commercial coverage that would bring Zepbound or Wegovy to $25/month at Mochi, Hims is costing you roughly $175 extra per month.
How it compares
vs. Ro: Ro has broader brand-name catalog and slightly deeper clinical. Hims is faster and bundles medication into the flat fee. If you want brand-name Zepbound, Ro. If you want the simplest possible experience, Hims.
vs. TrimRx: TrimRx is cheaper ($99/month) with similar clinical depth. Hims has better UX and brand polish. TrimRx is the budget pick; Hims is the budget pick with better logistics.
vs. Mochi Health: Not comparable. Mochi is a clinical program with insurance work; Hims is a cash-pay fulfillment service. Different products.
Verdict
Hims is the right program for a narrow but real customer: self-directed adults with uncomplicated medical history, no insurance coverage worth pursuing, and a preference for speed and simplicity. For that customer, $199/month flat with 72-hour medication delivery is genuinely best-in-class.
For everyone else — anyone with commercial insurance, anyone with comorbidities, anyone who wants clinical depth or behavioral support — Hims is the wrong program. Cheaper options exist for strict budget (TrimRx). Better clinical exists for complex cases (Form Health). Better insurance coverage exists almost everywhere else (Mochi Health).
Pricing breakdown
| Line item | Amount | Note |
|---|---|---|
| Hims Weight Loss (all-in) | $199/month | Includes compounded medication + prescriber |
| Wegovy Pill option | $149–$299/month | Promotional pricing may rise after month 3 |
| Labs | Usually $0 | Not required at first prescription in most states |
Is Hims Weight Loss right for you?
- Self-directed adults who've researched GLP-1s and want a fast, simple start.
- Cash-pay patients with uncomplicated medical history.
- Patients already working with a PCP for labs and broader health management.
- Anyone with meaningful commercial insurance coverage for GLP-1s.
- Patients with comorbidities (diabetes, heart disease, depression) needing coordinated care.
- Patients who want brand-name Zepbound or injectable Wegovy — catalog is limited.
- Patients seeking behavioral support or dietitian coaching.
Alternatives worth considering
Frequently asked questions
How much does Hims weight loss cost?
$199/month flat — includes compounded GLP-1 medication and prescriber access. Hims offers a Wegovy Pill option at $149–$299/month (promotional). No insurance acceptance.
How fast can I get GLP-1 medication from Hims?
Typically 2–3 days from signup to shipped medication. Intake is about 10 minutes; prescriber review usually same-day; shipping within 48 hours. No labs required in most states at first prescription.
Does Hims prescribe Zepbound?
Not at scale as of April 2026. Hims' GLP-1 catalog is primarily compounded semaglutide or tirzepatide plus the Wegovy Pill. Patients who specifically want brand-name Zepbound should look at Ro, Mochi Health, or LillyDirect.
Is Hims legit for weight loss?
Yes — Hims is a publicly traded U.S. telehealth company with licensed prescribers and pharmacy network partners. The service itself is legitimate. The question for any given patient is whether the minimal-support, cash-pay model is the right fit.
Can I use insurance with Hims?
No. Hims is cash-pay only. Patients with commercial insurance that covers GLP-1s will pay significantly less at insurance-accepting programs.
See the full program comparison or take the Sherpa Matcher quiz to see if Hims Weight Loss is your best fit.